Be Biopharma (“Be Bio”), whose mission is to pioneer the emerging new category of engineered B cells as medicines, today announced that Joanne Smith-Farrell, Ph.D., has been appointed Chief Executive Officer and Director. Dr. Smith-Farrell will be joined by Chief Scientific Officer, Richard Morgan, Ph.D., a leading expert in cell and gene therapies.

https://www.businesswire.com/news/home/20210316005398/en/Be-Bio-Announces-Appointment-of-Cell-and-Gene-Therapy-Veterans-Joanne-Smith-Farrell-Ph.D.-as-Chief-Executive-Officer-and-Rick-Morgan-Ph.D.-as-Chief-Scientific-Officer